Lidocaine Hydrochloride NDC 62135-712

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-712Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0712Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-712-42	62135071242	100 mL in 1 BOTTLE (62135-712-42)Marketed from Jun 16, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidocaine Hydrochloride
Generic name (nonproprietary): lidocaine hydrochloride
Active ingredients: Lidocaine hydrochloride anhydrous — 20 mg/mL
Dosage form: Solution
Route: Oropharyngeal
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040708
Marketing start: Feb 27, 2007
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 62135-712_4936d399-9101-8558-e063-6294a90a639cSPL ID 4936d399-9101-8558-e063-6294a90a639cSPL set ID c05f49a2-7512-48e7-9730-f8ee05519b9dRxCUI 1010739UNII EC2CNF7XFPUPC 0362135712426
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N462135071242 followed by a unit qualifier and the quantity

Package 62135-0712-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 25, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lidocaine hydrochloride oral topical solution USP, 2% (viscous) is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is also useful for reducing gagging during the taking of X-ray pictures and dental impressions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040708

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040708
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	SolutionOropharyngeal	Chartwell Governmental & Specialty RX, LLC.	68999-871
Lidocaine Hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	SolutionOropharyngeal	Chartwell RX, LLC	62135-871